New York, NY, United States of America

Kami Kim

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • San Francisco, CA (US) (1997)
  • New York, NY (US) (1999 - 2013)

Company Filing History:


Years Active: 1997-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Kami Kim

Introduction

Kami Kim is a notable inventor based in New York, NY (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of protozoan parasite infections. With a total of 3 patents, her work has had a meaningful impact on medical research and treatment methodologies.

Latest Patents

Kami Kim's latest patents include innovative approaches to combating protozoan parasites. One of her key inventions is titled "Analogues of coformycin and their use for treating protozoan parasite infections." This invention relates to compounds that are analogues of coformycin, pharmaceutical compositions containing these compounds, and methods for using them to treat infections, especially malaria. Another significant patent is "Transfection and genetic manipulations in obligate intracellular." This patent describes a method of transient transfection of obligate intracellular parasites, which is utilized to develop a system for stable transformation using selectable genes. For instance, the introduction of the chloramphenicol acetyl transferase (CAT) gene fused to Toxoplasma flanking sequences, followed by chloramphenicol selection, results in parasites that stably express CAT. DNA hybridization analysis has indicated that the CAT gene was inserted via homologous recombination.

Career Highlights

Throughout her career, Kami Kim has worked with prestigious institutions, including Leland Stanford Junior University and Industrial Research Limited. Her research has focused on developing innovative solutions to complex biological challenges, particularly in the realm of infectious diseases.

Collaborations

Kami has collaborated with esteemed colleagues in her field, including Dominique Soldati and John Charles Boothroyd. These collaborations have further enhanced her research and contributed to the advancement of knowledge in her area of expertise.

Conclusion

Kami Kim's contributions to the field of pharmaceutical sciences and her innovative patents demonstrate her commitment to improving treatments for protozoan infections. Her work continues to inspire future research and development in this critical area of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…